Factors associated with willingness to take extended release naltrexone among injection drug users

BACKGROUND: Although opioid-agonist therapy with methadone or buprenorphine/naloxone is currently the mainstay of medical treatment for opioid use disorder, these medications often are not well accepted or tolerated by patients. Recently, extended release naltrexone (XR-NTX), an opioid antagonist, h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Addict Sci Clin Pract
Main Authors: Ahamad, Keith, Milloy, MJ, Nguyen, Paul, Uhlmann, Sasha, Johnson, Cheyenne, Korthuis, Todd P, Kerr, Thomas, Wood, Evan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636793/
https://ncbi.nlm.nih.gov/pubmed/25935714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13722-015-0034-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares